| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/28/2006 | US7018803 Inhibitors of collagen assembly |
| 03/28/2006 | US7018791 chaperone proteins; biochemical immobilization; competitive binding; drug screening |
| 03/28/2006 | US7018639 polypeptide and optionally carrier and/or adjuvants having haemolysin activity used for inoculation against gramnegative bacteria; immunology |
| 03/28/2006 | US7018637 Vaccines; immunology carrier containing epitope binding tocarbohydrates |
| 03/28/2006 | US7018634 Surface proteins of Leptospira |
| 03/28/2006 | US7018626 Chimeric IL-10 |
| 03/28/2006 | US7018616 detection of serum antibodies to tuberculosis using fluorescent dyes conjugated to antigens, then evaluation using analyzing apparatus; biossays |
| 03/28/2006 | US7018610 Poly-L-R-Y, where poly represents a polymer( such as polystyrene homo or copolymer) R= aryl or heteroaryl, L= R3-Sn-R3 (R3= alkyl, alenyl or alkynyl), Y= hydrogen, alkyl, alkoxy, carbonyl, formyl, amido, amino, carobxyamido etc. |
| 03/28/2006 | US7018431 Useful as fluorescent labels of nucleosides, nucleotides, polynucleotides, and polypeptides. |
| 03/28/2006 | US7018334 Imaging of a region in a scattering medium |
| 03/28/2006 | CA2131874C Diagnostic reagents for the detection of antibodies to ebv |
| 03/28/2006 | CA2106719C Reshaped monoclonal antibodies against an immunoglobulin isotype |
| 03/28/2006 | CA2096723C Methods and compositions for the suppression of neu mediated transformation |
| 03/23/2006 | WO2006032016A2 P49/strap is a novel protein involved in gene regulation and cell proliferation |
| 03/23/2006 | WO2006031885A2 Kdr and vegf/kdr binding peptides |
| 03/23/2006 | WO2006031840A2 Increasing the stability of recombinant adult human apohemoglobin |
| 03/23/2006 | WO2006031727A2 Peptides for treatment of autoimmune diseases |
| 03/23/2006 | WO2006031689A2 Multimeric constructs |
| 03/23/2006 | WO2006031387A1 Thromboplastin reagents |
| 03/23/2006 | WO2006031363A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 03/23/2006 | WO2006031353A2 Vascular endothelial growth factor fusion constructs and uses thereof |
| 03/23/2006 | WO2006031330A2 METHOD OF REDUCING THE EFFECTS OF Aβ AND COMPOSITIONS THEREFORE |
| 03/23/2006 | WO2006031327A2 Cloning and expression of recombinant adhesive protein mefp-2 of the blue mussel, mytilus edulis |
| 03/23/2006 | WO2006031322A2 Determination of the 3d-structure of an extracellular domain of a b1 g-protein coupled receptor by nmr analysis |
| 03/23/2006 | WO2006031213A1 Single -pass image warping system and mehtod with anisotropic filtering |
| 03/23/2006 | WO2006031210A1 Jabi as a prognostic marker and a therapeutic target for human cancer |
| 03/23/2006 | WO2006030840A1 Process for synthesis of mucin-type peptides and muc1-related glycopeptides |
| 03/23/2006 | WO2006030761A1 Novel diabetes-associated factor |
| 03/23/2006 | WO2006030722A1 Amino acid sequence essential to neurospecific gene expression |
| 03/23/2006 | WO2006030638A1 Lectin specific to discorea opposita-origin mannose and gene thereof |
| 03/23/2006 | WO2006030445A2 Isolated polypeptides and polynucleotides encoding same for generating plants with increased cuticlar water permeability |
| 03/23/2006 | WO2006029891A2 Change of the load state of mhc molecules |
| 03/23/2006 | WO2006029852A1 Polypeptide species useful for the treatment of neurological disorders |
| 03/23/2006 | WO2006029775A1 Method for removing fibronectin from plasma fractions |
| 03/23/2006 | WO2006029774A1 Production of a von willebrand factor preparation having a great specific activity |
| 03/23/2006 | WO2006029773A1 Production of a von willebrand factor preparation using hydroxylapatite |
| 03/23/2006 | WO2006029735A1 Diagnostics and therapeutics for diseases associated with prostaglandin 12 receptor (ptgir) |
| 03/23/2006 | WO2006029719A2 Diagnostics and therapeutics for diseases associated with nuclear receptor subfamily 1, group h, member 4 (nr1h4) |
| 03/23/2006 | WO2006029632A2 Chimeric phage-derived particles, methods for their production and use |
| 03/23/2006 | WO2006029578A1 Interleukin-15 antagonist peptide |
| 03/23/2006 | WO2006029492A1 Kunitz-type recombinant inhibitor. |
| 03/23/2006 | WO2006029487A2 Platelet factor 4 variant 1 (pf4var1) related inhibitors of angiogenesis |
| 03/23/2006 | WO2006029459A1 Antibodies specific for hepatocellular carcinoma and other carcinomas and uses thereof |
| 03/23/2006 | WO2006020748A2 Gfp-snap25 fluorescence release assay for botulinum toxin protease activity |
| 03/23/2006 | WO2006010138A9 Bioactive chemokine heteromultimers |
| 03/23/2006 | WO2006005520A3 Means and methods for controlling flowering in plants |
| 03/23/2006 | WO2005121354A3 Peptide substrates recognisable by a botulinum toxin a, bont/a and the use thereof |
| 03/23/2006 | WO2005121163A3 Isolation of plasma or serum proteins |
| 03/23/2006 | WO2005117956A3 Neisserial vaccines |
| 03/23/2006 | WO2005116222A3 Gene-cassette for enhancement of protein production |
| 03/23/2006 | WO2005110491A8 Inducible dimerization of growth factor receptors for treating cancer |
| 03/23/2006 | WO2005107396A3 Novel compositions and methods in cancer |
| 03/23/2006 | WO2005098051A3 Hsv-2 type-specific immunoassays using glycoprotein g2 peptides |
| 03/23/2006 | WO2005097981A3 Novel herpes simplex viruses |
| 03/23/2006 | WO2005095975A3 Anti-fungal target genes |
| 03/23/2006 | WO2005094785A3 Compositions capable of facilitating penetration across a biological barrier |
| 03/23/2006 | WO2005092016A3 Compositions and methods for controlling insects related to the octopamine receptor |
| 03/23/2006 | WO2005067368A3 Production of glucagon like peptide 2 and analogs |
| 03/23/2006 | WO2005065017A3 Methods of inducing il-10 production |
| 03/23/2006 | WO2005059133A3 Combination therapy associating a tgf-breta antagonist with a chemiotherapeutic agent |
| 03/23/2006 | WO2005058006A3 Methods and compositions comprising bacteriophage nanoparticles |
| 03/23/2006 | WO2005050201A3 Hairless protein-interacting partner complexes and methods thereof for the beautification and/or improvement of mammalian skin |
| 03/23/2006 | WO2005049794A3 Methods of characterizing infectious bursal disease virus |
| 03/23/2006 | WO2005048985A3 Alpha 1-antitrypsin compositions and treatment methods using such compositions |
| 03/23/2006 | WO2005048913A3 Mutant lrp5/6 wnt-signaling receptors in cancer diagnosis, prognosis and treatment |
| 03/23/2006 | WO2005047459A3 Sars nucleic acids, proteins, antibodies, and uses thereof |
| 03/23/2006 | WO2005044980A3 Zap protein and related compositions and methods |
| 03/23/2006 | WO2005042006A3 Use of ephrins and related molecules to regulate cellular proliferation |
| 03/23/2006 | WO2005040191A3 Ccn1 compositions and methods |
| 03/23/2006 | WO2005033125A3 Mammalian t1r3 sweet taste receptors |
| 03/23/2006 | WO2005013802A3 Trefoil factor 3 (tff3) as a target for anti-cancer therapy |
| 03/23/2006 | WO2004111087A3 Chemokin-binding protein thap1, methods and use thereof |
| 03/23/2006 | WO2004110349A3 Sars t cell epitopes and methods for identifying same |
| 03/23/2006 | WO2004108939A3 BAV packaging regions and E1 transcriptional control regions |
| 03/23/2006 | WO2004101799A3 Broadening adenovirus tropism |
| 03/23/2006 | WO2004098502A3 Cngh0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses. |
| 03/23/2006 | WO2004096254A3 Transferrin conjugates for tumor treatment |
| 03/23/2006 | WO2004087057A3 Methods for inhibition of angiogenesis |
| 03/23/2006 | WO2004056970A3 Chemo-enzymatic process for proteome-wide mapping of post-translational modification |
| 03/23/2006 | WO2004038008A3 Modulation of cellular proliferation |
| 03/23/2006 | WO2004011618A3 Methods of identifying adipocyte specific genes, the genes identified, and their uses |
| 03/23/2006 | WO2004005485A3 Compositions and methods for controlling parasitic nematodes |
| 03/23/2006 | WO2003087299A3 Methods of characterizing molecular interaction sites on proteins |
| 03/23/2006 | WO2003083085A3 Transporters and ion channels |
| 03/23/2006 | WO2003049602A3 Diagnostic methods for protein profiling |
| 03/23/2006 | US20060064785 Transgenic plant comprising an exogenous nucleic acid; modulation of hormone levels prior to the onset of stress provides plants with better stress tolerance. |
| 03/23/2006 | US20060064778 Using vector transformation to insert plasmid which express antisense sequences which reduce proanthocyanidin (PA) in plant seed coats; enhancing feed quality and digestibility |
| 03/23/2006 | US20060064775 Method for increasing resistance against stress factors in plants |
| 03/23/2006 | US20060064766 Histamine receptor h3 modified transgenic mice |
| 03/23/2006 | US20060064765 Obesity gene |
| 03/23/2006 | US20060064764 Increasing gamete production with a gene switch |
| 03/23/2006 | US20060064252 Small molecule mimetics of erythropoietin |
| 03/23/2006 | US20060063924 Leukocyte regulatory factors 1 and 2 |
| 03/23/2006 | US20060063923 4-1BB peptides and methods for use |
| 03/23/2006 | US20060063922 Epidermal differentiation factor |
| 03/23/2006 | US20060063920 Method and system for extraction of oil from corn |
| 03/23/2006 | US20060063919 Self-assembling-peptide-based structures and processes for controlling the self-assembly of such structures |
| 03/23/2006 | US20060063914 Peptides having protected amines of untargeted sites, methods for production thereof and of specifically conjugated peg peptides using the same |
| 03/23/2006 | US20060063913 SSX-2 peptide analogs |
| 03/23/2006 | US20060063807 Low molecular weight peptidomimetic growth hormone secretagogues |